Susquehanna initiated coverage of Macom (MTSI) with a Neutral rating and $200 price target The company is well positioned across multiple long-term growth vectors gave its “differentiated” compound semiconductor capabilities in gallium arsenide, gallium nitride, and indium phosphide, the analyst tells investors in a research note. However, Susquehanna cites Macom’s “elevated” valuation” for the Neutral rating.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSI: